Effectiveness of rosemary extract on the cardiovascular risk of emergency nursing professionals - an intervention study.

Oral administration of rosemary dry extract capsules significantly reduced estimated cardiovascular risk as measured by the Framingham Global Risk Score.

• Participants took 500 mg of dry rosemary extract twice a day (1g/day total) for 8 weeks
• The Framingham Global Risk Score showed a statistically significant difference before and after intervention (p = 0.047)
• The study used a quasiexperimental design with pre- and post-intervention blood sampling
• 36 professionals completed the study

Total cholesterol levels showed a statistically significant difference following the 8-week rosemary extract intervention.

• The difference in total cholesterol before and after intervention was statistically significant (p < 0.001)
• The study population was predominantly composed of individuals with elevated total cholesterol at baseline
• Blood was collected for glycemic and lipid profile analysis at baseline and after the 8-week intervention

Blood pressure showed a statistically significant difference following the rosemary dry extract intervention.

• The difference in blood pressure before and after intervention reached statistical significance (p = 0.048)
• The significance level used for all analyses was 5%
• Data analysis used both descriptive and inferential statistics

The study population of emergency nursing professionals was predominantly obese and had elevated total cholesterol at baseline.

• 36 professionals completed the study
• The study was conducted in Southern Brazil
• Participants completed a sociodemographic and clinical questionnaire as part of baseline assessment
• The population worked in emergency and urgent care services

The study used the Framingham Global Risk Score to estimate 10-year cardiovascular risk before and after rosemary extract intervention.

• The Framingham Global Risk Score was used to estimate cardiovascular risk over ten years
• The intervention consisted of oral capsules containing 500 mg of dry rosemary extract taken twice a day for 8 weeks
• The study was registered in the Brazilian Registry of Clinical Trials (No. RBR 88hrnnw)
• A quasiexperimental design was employed with pre- and post-intervention comparisons